These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 30997749)
1. Activated cytotoxic T cells within zoonotic cutaneous leishmaniasis lesions. Boussoffara T; Boubaker MS; Ben Ahmed M; Mokni M; Feriani S; Ben Salah A; Louzir H Immun Inflamm Dis; 2019 Sep; 7(3):95-104. PubMed ID: 30997749 [TBL] [Abstract][Full Text] [Related]
2. Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum. Boussoffara T; Boubaker MS; Ben Ahmed M; Mokni M; Guizani I; Ben Salah A; Louzir H Parasite; 2019; 26():9. PubMed ID: 30810524 [TBL] [Abstract][Full Text] [Related]
3. Immunity Against Boussoffara T; Chelif S; Ben Ahmed M; Mokni M; Ben Salah A; Dellagi K; Louzir H Front Cell Infect Microbiol; 2018; 8():397. PubMed ID: 30483482 [TBL] [Abstract][Full Text] [Related]
4. CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis. Nateghi Rostami M; Keshavarz H; Edalat R; Sarrafnejad A; Shahrestani T; Mahboudi F; Khamesipour A PLoS Negl Trop Dis; 2010 Oct; 4(10):e845. PubMed ID: 20967288 [TBL] [Abstract][Full Text] [Related]
5. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis. Santos Cda S; Boaventura V; Ribeiro Cardoso C; Tavares N; Lordelo MJ; Noronha A; Costa J; Borges VM; de Oliveira CI; Van Weyenbergh J; Barral A; Barral-Netto M; Brodskyn CI J Invest Dermatol; 2013 Jun; 133(6):1533-40. PubMed ID: 23321919 [TBL] [Abstract][Full Text] [Related]
6. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects. Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691 [TBL] [Abstract][Full Text] [Related]
7. Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis. Bousoffara T; Louzir H; Ben Salah A; Dellagi K J Infect Dis; 2004 Apr; 189(7):1265-73. PubMed ID: 15031796 [TBL] [Abstract][Full Text] [Related]
8. A Prospective cohort study of zoonotic cutaneous leishmaniasis in tunisia: Clinical and Immunological features and immune correlates of protection. Naouar I; Kammoun Rebai W; Ben Salah A; Bouguerra H; Toumi A; Hamida NB; Louzir H; Meddeb-Garnaoui A PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011784. PubMed ID: 38064516 [TBL] [Abstract][Full Text] [Related]
9. Involvement of different CD4(+) T cell subsets producing granzyme B in the immune response to Leishmania major antigens. Naouar I; Boussoffara T; Ben Ahmed M; Belhaj Hmida N; Gharbi A; Gritli S; Ben Salah A; Louzir H Mediators Inflamm; 2014; 2014():636039. PubMed ID: 25104882 [TBL] [Abstract][Full Text] [Related]
10. Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8 Covre LP; Devine OP; Garcia de Moura R; Vukmanovic-Stejic M; Dietze R; Ribeiro-Rodrigues R; Guedes HLM; Lubiana Zanotti R; Falqueto A; Akbar AN; Gomes DCO Immunology; 2020 Apr; 159(4):429-440. PubMed ID: 31925782 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic and Functional Profiles of Antigen-Specific CD4 Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917 [TBL] [Abstract][Full Text] [Related]
12. PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Barroso DH; Falcão SAC; da Motta JOC; Sevilha Dos Santos L; Takano GHS; Gomes CM; Favali CBF; de Lima BD; Sampaio RNR Front Immunol; 2018; 9():1021. PubMed ID: 29867989 [TBL] [Abstract][Full Text] [Related]
13. Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis. Campos TM; Novais FO; Saldanha M; Costa R; Lordelo M; Celestino D; Sampaio C; Tavares N; Arruda S; Machado P; Brodskyn C; Scott P; Carvalho EM; Carvalho LP J Infect Dis; 2020 Mar; 221(6):973-982. PubMed ID: 31748808 [TBL] [Abstract][Full Text] [Related]
18. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Kemp M; Hey AS; Kurtzhals JA; Christensen CB; Gaafar A; Mustafa MD; Kordofani AA; Ismail A; Kharazmi A; Theander TG Clin Exp Immunol; 1994 Jun; 96(3):410-5. PubMed ID: 8004809 [TBL] [Abstract][Full Text] [Related]
19. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles. Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546 [TBL] [Abstract][Full Text] [Related]
20. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. Louzir H; Melby PC; Ben Salah A; Marrakchi H; Aoun K; Ben Ismail R; Dellagi K J Infect Dis; 1998 Jun; 177(6):1687-95. PubMed ID: 9607850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]